These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 11591358)
1. Effects of perindopril on cardiovascular remodeling. McVeigh GE Am J Cardiol; 2001 Oct; 88(7A):28i-35i. PubMed ID: 11591358 [TBL] [Abstract][Full Text] [Related]
2. Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril. Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Lederballe O Blood Press; 1995 Jul; 4(4):241-8. PubMed ID: 7496564 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of perindopril in the treatment of systemic hypertension. Oparil S Am J Cardiol; 2001 Oct; 88(7A):3i-12i. PubMed ID: 11591355 [TBL] [Abstract][Full Text] [Related]
4. Perindopril: an updated review of its use in hypertension. Hurst M; Jarvis B Drugs; 2001; 61(6):867-96. PubMed ID: 11398915 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril. Ferrari R Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572 [TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. Ferrari R; Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606 [TBL] [Abstract][Full Text] [Related]
7. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS). Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS; Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735 [TBL] [Abstract][Full Text] [Related]
8. Vascular effects of perindopril: from experimental to clinical investigation. Scalbert E; Levy B; Desche P; Devissaguet M; Safar ME J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S25-32. PubMed ID: 1725197 [TBL] [Abstract][Full Text] [Related]
9. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension. Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083 [TBL] [Abstract][Full Text] [Related]
10. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril]. Rapezzi C; Ciliberti P; Graziosi M; Riva L Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516 [TBL] [Abstract][Full Text] [Related]
11. [Effect of twelve-month combined therapy with perindopril and indapamide on the level of blood pressure and left ventricular hypertrophy in patients with hypertensive disease]. Timofeeva LA; Alekhin MN; Ugriumov MO; Chumakova OS; Larina VN; Sidorenko BA Kardiologiia; 2006; 46(3):30-4. PubMed ID: 16710252 [TBL] [Abstract][Full Text] [Related]
12. Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects independent of anti-hypertensive effect. Watanabe Y; Takasugi E; Shitakura K; Okajima K; Hota N; Kubo Y; Nunoda S; Otsuka K Clin Exp Hypertens; 2011; 33(4):246-54. PubMed ID: 21699451 [TBL] [Abstract][Full Text] [Related]
13. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension. Anan F; Takahashi N; Ooie T; Yufu K; Hara M; Nakagawa M; Yonemochi H; Saikawa T; Yoshimatsu H Eur J Clin Pharmacol; 2005 Jul; 61(5-6):353-9. PubMed ID: 15918057 [TBL] [Abstract][Full Text] [Related]